Lemos et al. conducted a study in Brazil executed by RT-PCR for the detection of BCR-ABL on 22 CML patients, in which 59% of the patients showed b3a2 and 41% showed b2a2 transcripts. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.